Effect of Structure and Composition on Ibuprofen Drug Delivery by Calcium Phosphate Nanocarriers


Article Preview

The effect of structure and composition of calcium phosphate (CaP) nanoparticles namely hydroxyapatite (HA), calcium deficient hydroxyapatite (CDHA) with Ca/P ratio ranging from 1.33 to 1.61 and tricalcium phosphate (β-TCP), on the efficiency of nanoparticles as an ideal drug carrier have been investigated. Ibuprofen, an anti-inflammatory drug was chosen for this study. The CaP nanoparticles were prepared by microwave accelerated wet chemical synthesis method and were characterized by X-ray powder diffraction, infrared spectroscopy, and electron microscopic techniques. The loading and release profiles of ibuprofen from the nanocarriers was studied using UV-Vis spectroscopy. Maximum loading of the drug was observed in β-TCP (75%) followed by CDHA of Ca/P ratio 1.5. Both samples have same Ca/P ratio but have different crystal structure. Low amount of drug loading was observed in HA and other CDHAs which have Ca/P ratio different from 1.5. Although, all the samples exhibits sustained release of ibuprofen for about 7 days, the maximum release was also shown by β-TCP (26%). Among HA and CDHAs, the amount of ibuprofen release increases with increasing Ca/P ratio. The loading and release profile of ibuprofen drug seems to be strongly related to the Ca/P ratio and structure of CaP nanocarriers.



Key Engineering Materials (Volumes 529-530)

Main Theme:

Edited by:

Kunio Ishikawa and Yukihide Iwamoto




K. Madhumathi and T.S. Sampath Kumar, "Effect of Structure and Composition on Ibuprofen Drug Delivery by Calcium Phosphate Nanocarriers", Key Engineering Materials, Vols. 529-530, pp. 495-500, 2013

Online since:

November 2012




[1] A. Siddharthan, S.K. Seshadhri, T.S. Sampath Kumar, Microwave accelerated synthesis of nanosized calcium deficient hydroxyapatite, J. Mater. Sci.: Mater. Med. 15(2004)1279-84.

DOI: https://doi.org/10.1007/s10856-004-5735-3

[2] S.P. Victor and T.S. Sampath Kumar, Tailoring calcium-deficient hydroxyapatite nanocarriers for enhanced release of antibiotics, J. Biomed. Nanotech, 4(2008)1-7.

[3] V. Uskokovic and D.P. Uskokovic, Nanosized hydroxyapatite and other calcium phosphates: Chemistry of formation and application as drug and gene delivery agents, J. Biomed. Mater. Res., 96B(2011) 152-191.

DOI: https://doi.org/10.1002/jbm.b.31746

[4] R. Gibson,I. Rehman S.M. Best and W. Bonfield, Characterization of the transformation from calcium deficient apatite to β-Tricalcium phosphate, J. Mater. Sci: Mater. Med. 12(2000)799-804.